Curaleaf Holdings (CURLF) Accounts Payables (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Accounts Payables of $74.7 million for Q4 2025, down 5.57% year-over-year from $79.1 million in Q4 2024, and down 5.57% quarter-over-quarter from $79.1 million in Q4 2024.
Curaleaf Holdings (CURLF) Accounts Payables (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Accounts Payables history runs 7 years deep, the most recent figure standing at $74.7 million for Q4 2025.
- In Q4 2025, Accounts Payables fell 5.57% year-over-year to $74.7 million; the TTM figure through Dec 2025 stood at $74.7 million (down 5.57% YoY), while the FY2025 annual figure was $74.7 million, down 5.57% from the prior year.
- Accounts Payables for Q4 2025 stood at $74.7 million, down from $79.1 million in the prior quarter.
- The five-year high for Accounts Payables was $101.9 million in Q2 2024, with the low at $38.7 million in Q1 2021.
- The 5-year median for Accounts Payables is $69.6 million (2022), against an average of $68.4 million.
- The sharpest annual moves came in 2021 and 2022: Accounts Payables soared 97.31% in 2021, then declined 17.09% in 2022.
- Curaleaf Holdings' Accounts Payables stood at $60.8 million in 2021, then slipped by 17.09% to $50.4 million in 2022, then soared by 57.45% to $79.3 million in 2023, then decreased by 0.24% to $79.1 million in 2024, then retreated by 5.57% to $74.7 million in 2025.
- Business Quant data shows CURLF's Accounts Payables at $74.7 million in Q4 2025, $79.1 million in Q4 2024, and $89.8 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | Curaleaf Holdings | 2.51 Bn | 2.42 Bn | 169.91 Mn | 60.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 60.07 Mn |
| Dec 31, 2025 | 74.73 Mn |
| Dec 31, 2024 | 79.13 Mn |
| Sep 30, 2024 | 89.75 Mn |
| Jun 30, 2024 | 101.89 Mn |
| Dec 31, 2023 | 79.32 Mn |
| Sep 30, 2023 | 63.72 Mn |
| Jun 30, 2023 | 69.36 Mn |
| Sep 30, 2022 | 50.38 Mn |
| Mar 31, 2022 | 69.88 Mn |
| Sep 30, 2021 | 60.76 Mn |
| Jun 30, 2021 | 42.96 Mn |
| Mar 31, 2021 | 38.65 Mn |
| Dec 31, 2020 | 47.04 Mn |
| Sep 30, 2020 | 30.80 Mn |
| Dec 31, 2019 | 12.74 Mn |